Form CORRESP - Correspondence:
SEC Accession No. 0001558370-25-002216
Filing Date
2025-03-05
Accepted
2025-03-05 10:00:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11517
  Complete submission text file 0001558370-25-002216.txt   12572
Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)